Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000930413-24-002002
Filing Date
2024-07-03
Accepted
2024-07-03 17:31:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 c109281_sch13da.htm SC 13D/A 64194
2 c109281_ex99-2.htm EX-99.2 7970
  Complete submission text file 0000930413-24-002002.txt   73864
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Subject) CIK: 0001898416 (see all company filings)

EIN.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93700 | Film No.: 241101048
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5, RUE HEIENHAFF L-1736 SENNINGERBERG GRAND DUCHY N4 00000
Business Address 5, RUE HEIENHAFF L-1736 SENNINGERBERG GRAND DUCHY N4 00000 359 691 211 663
Aztiq Pharma Partners S.a r.l. (Filed by) CIK: 0001936288 (see all company filings)

EIN.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A